EUROPEAN HEALTH STAKEHOLDERS NETWORK

Welcome Guest! | Log In
Articles
  • Prostate cancer is the most common male cancer and probably the most controversial in terms of how it is managed.  The two largest errors that result from the current pathway are the problems over-diagnosis and over-treatment.  Just under half of men currently screened may fall into this category. The problem of under-diagnosis (clinically important prostate cancer that is...

  • Despite significant advances in the diagnosis and treatment of prostate cancer, the disease remains the second-most frequently diagnosed cancer and one of the leading causes of cancer-related death in men around the world, according to the International Agency for Cancer Research.  Approximately 90 percent of men with castration resistant prostate cancer (CRPC) have radiological evidence...

  • In the physiological preservation of biological balance, tissues renew by means of stem or stem-like cells. Thus, during the differentiative processes aimed at the configuration of the tissue, there is a sequence of mother stem cells, daughter stem cells – lacking the unlimited number of replications – and T.A.Cs (Transit Amplifying Cells), until structural completion. Therefore,...

  • Indentifying the Etiologic or the risk factors that induce prostate cancer, one of the most frequent cancers in men, would be an important step to start with.

    The worldwide variation of the incidence and mortality of prostate cancer, with the highest rates in North America and the lowest in Asian Countries and Japan strongly suggests that multi – factorial elements such as...

  • Prostate cancer is being diagnosed more than in the past, and, as a consequence, patients are often being treated at an earlier disease stage. In contrast to patients with more advanced disease, such as those with castration-resistant prostate cancer (CRPC), these earlier-stage prostate cancer patients are generally not at risk of imminent death. However, they are still in need of medicinal...

  • The dramatic growth in scientific research focused prostate cancer continues to challenge health professionals and public health authorities worldwide. Recent publications concerning the efficacy of prostate cancer screening have fuelled public debate concerning appropriate testing policies. Improvements in health care and an aging population in the EU suggest that the management of prostate...

  • The present document summarises the conclusions of the 2006 report from the Belgian Health Care Knowledge Centre (KCE): Prostate-specific-antigen (PSA) in prostate cancer screening”. In 2009,  KCE issued a report on “Robot-assisted surgery” which covered prostate surgery and indirectly PSA as well. Both reports are...